Alzheimer's Disease: An Overview of Recent Developments and a Look to the Future
- PMID: 31975835
- PMCID: PMC6519622
- DOI: 10.1176/appi.focus.20160029
Alzheimer's Disease: An Overview of Recent Developments and a Look to the Future
Abstract
Alzheimer's disease is a major public health concern, affecting an estimated 40 million people worldwide. Over the past few years, several new diagnostic tests and new diagnostic nomenclatures have emerged, and more than 70 disease-modifying agents are in clinical trials. Naturalistic studies that include biomarkers-such as genomics, metabolomics, and imaging-have yielded additional insights into disease mechanisms and timelines of preclinical disease onset. This article reviews recent developments in epidemiology, diagnostic criteria, and diagnostic tests; provides updates on symptomatic therapies, ongoing prevention trials, and neuropsychiatric symptom treatment options; and ends with a discussion on prospects for a cure.
Keywords: Dementia-Alzheimer’s Disease.
Copyright © 2017 by the American Psychiatric Association.
Similar articles
-
2021 Alzheimer's disease facts and figures.Alzheimers Dement. 2021 Mar;17(3):327-406. doi: 10.1002/alz.12328. Epub 2021 Mar 23. Alzheimers Dement. 2021. PMID: 33756057
-
The future of Alzheimer's disease: the next 10 years.Prog Neurobiol. 2011 Dec;95(4):718-28. doi: 10.1016/j.pneurobio.2011.11.008. Epub 2011 Nov 22. Prog Neurobiol. 2011. PMID: 22137045 Review.
-
Recent developments in Alzheimer's disease therapeutics.BMC Med. 2009 Feb 19;7:7. doi: 10.1186/1741-7015-7-7. BMC Med. 2009. PMID: 19228370 Free PMC article. Review.
-
2022 Alzheimer's disease facts and figures.Alzheimers Dement. 2022 Apr;18(4):700-789. doi: 10.1002/alz.12638. Epub 2022 Mar 14. Alzheimers Dement. 2022. PMID: 35289055
-
2023 Alzheimer's disease facts and figures.Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14. Alzheimers Dement. 2023. PMID: 36918389
Cited by
-
Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain.Theranostics. 2021 Jan 1;11(2):789-804. doi: 10.7150/thno.50263. eCollection 2021. Theranostics. 2021. PMID: 33391505 Free PMC article.
-
Cerebral Responses to Acupuncture at GV24 and Bilateral GB13 in Rat Models of Alzheimer's Disease.Behav Neurol. 2018 Apr 30;2018:8740284. doi: 10.1155/2018/8740284. eCollection 2018. Behav Neurol. 2018. PMID: 29854022 Free PMC article.
-
Neurocognitive Disorders in Geriatric Psychiatry.Focus (Am Psychiatr Publ). 2017 Jan;15(1):1-2. doi: 10.1176/appi.focus.20160041. Epub 2017 Jan 11. Focus (Am Psychiatr Publ). 2017. PMID: 31975832 Free PMC article. No abstract available.
-
Updates in Geriatric Psychiatry.Focus (Am Psychiatr Publ). 2021 Jul;19(3):338-339. doi: 10.1176/appi.focus.19301. Epub 2021 Jul 9. Focus (Am Psychiatr Publ). 2021. PMID: 34690603 Free PMC article. No abstract available.
-
[Progress in the study of the imaging genomics of Alzheimer's disease].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2019 Feb 25;36(1):140-145. doi: 10.7507/1001-5515.201805061. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2019. PMID: 30887788 Free PMC article. Review. Chinese.
References
-
- World Alzheimer Report 2015: The Global Impact of Dementia. London, Alzheimer’s Disease International, 2015.
-
- Scheltens P, Blennow K, Breteler MMB, et al. : Alzheimer’s disease. Lancet 2016; 388:505–517 - PubMed
-
- Yuan J, Zhang Z, Wen H, et al. : Incidence of dementia and subtypes: a cohort study in four regions in China. Alzheimers Dement 2016; 12:262–271 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous